Pharmacovigilance and side effects
Globe
medac group
|
All Countries

Media

Up to date with medac

Here you will find our latest news updates, press releases, photos for editorial use, information on upcoming events and other materials for download.
Up to date with medac

Newsroom

Press releases

Company updates, commentaries and product news: our newsroom provides you with all press releases from medac.

23.01.2025

Strategic cornerstone: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in adult and pediatric patients aged 1 year and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Find out more Find out more
Strategic cornerstone: FDA approves treosulfan for alloHSCT

17.10.2024

CDMO medac group at CPHI in Milan

medac group, a reliable partner in contract development and manufacturing, is pleased to report a series of productive and insightful meetings with both current and potential business partners during this year’s CPHI Congress in Milan, held from 8–10 October 2024.
Find out more Find out more
CDMO medac group at CPHI in Milan

Events

Event calendar

From congresses to exhibitions: an overview of all events where you can get in touch with medac.
Find out more External

Downloads

Download center

Press photos, guides, brochures and other materials from the medac universe to download.
Find out more External

Newsroom

Press releases

Company updates, commentaries and product news: our newsroom provides you with all press releases from medac.
Find out more External

Your contact for media enquiries

Are you a member of the media with questions about medac, our company or our products? Please contact our press office:
Lock

Login

Please enter your email address and password to log in.